Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement

Clinical and Translational Oncology

Volumn 8, Issue 5, 2006, Pages 369-371

  González Cao, María ^a   Bastarrika, Gorka ^b   García Foncillas, Jesús ^a   Aristu, Javier ^a   Chopitea, Ana ^a   Algarra, Salvador Martín ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Carcinoid tumor; Chemoembolization; Liposomal doxorubicin

Indexed keywords

DOXORUBICIN; SOMATOSTATIN DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; LIPOSOME;

ADULT; ANKLE EDEMA; ARTICLE; CARCINOID SYNDROME; CASE REPORT; CHEMOEMBOLIZATION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIARRHEA; DISEASE COURSE; DRUG RESPONSE; DRUG TOLERABILITY; DYSPNEA; FLUSHING; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; ILEUM; LIVER BIOPSY; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE REPLACEMENT; TUMOR VOLUME; WEIGHT REDUCTION; CARCINOID; HEART TUMOR; HEART VALVE REPLACEMENT; HEPATIC ARTERY; ILEUM TUMOR; INTRAARTERIAL DRUG ADMINISTRATION; LIVER TUMOR; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOID TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DOXORUBICIN; HEART FAILURE, CONGESTIVE; HEART NEOPLASMS; HEART VALVE PROSTHESIS IMPLANTATION; HEPATIC ARTERY; HUMANS; ILEAL NEOPLASMS; INJECTIONS, INTRA-ARTERIAL; LIPOSOMES; LIVER NEOPLASMS; MALE; MIDDLE AGED; TRICUSPID VALVE INSUFFICIENCY;

EID: 33747469010     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0184-8     Document Type: Article

References (12)

1. Williams ED, Sandler M. The classification of carcinoid tumors. Lancet. 1963;1: 238-9.
2. Caplin ME, Buscombe JR, Hilson AJ et al. Carcinoid tumour. Lancet. 1998;352:799-805.
3. Sutcliffe R, Maguire D, Ramage J et al. Management of neuroendocrine liver metastases. Am J Surg. 2004;187:39-46.
4. Jacobsen MB, Hanssen LE, Kolmannskog F et al. Interferon-alpha 2b, with or without prior hepatic artery embolization: Clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study. Scand J Gastroenterol. 1995; 30:789-96.
5. Plöckinger U, Rindi G, Arnold R et al. Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. Neuroendocrinology. 2004;80: 394-424.
6. Talamonti MS, Stuart KE, Yao JC. Neuroendocrine tumors of the gastrointestinal tract: How aggressive should we be? Educational Book of the ASCO. 2004. p. 206-18.
7. Roche A, Girish B, de Baere T et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol. 2003;13:136-40.
8. Hayek ER, Speakman E, Rehmus E. Acute doxorubicin cardiotoxicity. New Engl J Med. 2005;23:2456-7.
9. O'Brien MER, Wigler N, Inbar et al. Reduced cardiotoxicity and comparable efficacy in phase III trial of pegylated liposomal doxorubicin HCI (Caelyx/Doxil) versus conventional doxorubicin for firstline treatment of metastatic breast cancer. Ann Oncol. 2004;15:440-9.
10. Kruskalk JB, Cay O, Thomas P et al. Stealth liposomes: A promising agent for targeting hepatic colorectal cancer metastases. Radiology. 1996;201:320.
11. Cay O, Kruskal JB, Nasser I et al. Liver metastases from colorectal cancer: Drug delivery with liposome-encapsulated doxorubicin. Radiol. 1997;205:95-101.
12. Warner RRP. Carcinoid case presentation and discussion: The American perspective. Endocrine-related cancer. 2003;10:489-6.